Suppr超能文献

核干细胞蛋白:p53-MDM2 环中的另一个核仁“扭结”。

Nucleostemin: Another nucleolar "Twister" of the p53-MDM2 loop.

机构信息

Department of Biochemistry and Molecular Biology, Indiana University School of Medicine-Simon Cancer Center, Indianapolis, Indiana, USA.

出版信息

Cell Cycle. 2010 Aug 15;9(16):3227-32. doi: 10.4161/cc.9.16.12605. Epub 2010 Aug 4.

Abstract

Several nucleolar proteins, such as ARF, ribosomal protein (RP) L5, L11, L23 and S7, have been shown to induce p53 activation by inhibiting MDM2 E3 ligase activity and consequently to trigger cell cycle arrest and/or apoptosis. Our recent study revealed another nucleolar protein called nucleostemin (NS), a nucleolar GTP binding protein, as a novel regulator of the p53-MDM2 feedback loop. However, unlike other known nucleolar regulators of this loop, NS surprisingly plays a dual role, as both up and downregulations of its levels could turn on p53 activity. Here, we try to offer some prospective views for this unusual phenomenon by reconciling previously and recently published studies in the field in hoping to better depict the role of NS in linking the p53 pathway with ribosomal biogenesis during cell growth and proliferation as well as to propose NS as another potential molecular target for anti-cancer drug development.

摘要

几种核仁蛋白,如 ARF、核糖体蛋白(RP)L5、L11、L23 和 S7,已被证明通过抑制 MDM2 E3 连接酶活性来诱导 p53 激活,从而引发细胞周期停滞和/或细胞凋亡。我们最近的研究揭示了另一种核仁蛋白称为核干细胞蛋白(NS),它是一种核仁 GTP 结合蛋白,作为 p53-MDM2 反馈回路的新型调节剂。然而,与该回路的其他已知核仁调节剂不同,NS 出人意料地发挥双重作用,因为其水平的上调和下调都可以激活 p53 活性。在这里,我们试图通过整合该领域之前和最近发表的研究来提供一些前瞻性观点,希望更好地描述 NS 在将 p53 途径与细胞生长和增殖过程中的核糖体生物发生联系起来的作用,并提出 NS 作为另一种潜在的抗癌药物开发的分子靶标。

相似文献

1
Nucleostemin: Another nucleolar "Twister" of the p53-MDM2 loop.
Cell Cycle. 2010 Aug 15;9(16):3227-32. doi: 10.4161/cc.9.16.12605. Epub 2010 Aug 4.
2
Aberrant expression of nucleostemin activates p53 and induces cell cycle arrest via inhibition of MDM2.
Mol Cell Biol. 2008 Jul;28(13):4365-76. doi: 10.1128/MCB.01662-07. Epub 2008 Apr 21.
3
Ubiquitin- and MDM2 E3 ligase-independent proteasomal turnover of nucleostemin in response to GTP depletion.
J Biol Chem. 2012 Mar 23;287(13):10013-10020. doi: 10.1074/jbc.M111.335141. Epub 2012 Feb 8.
4
PAK1IP1, a ribosomal stress-induced nucleolar protein, regulates cell proliferation via the p53-MDM2 loop.
Nucleic Acids Res. 2011 Mar;39(6):2234-48. doi: 10.1093/nar/gkq1117. Epub 2010 Nov 21.
5
Perturbation of 60 S ribosomal biogenesis results in ribosomal protein L5- and L11-dependent p53 activation.
J Biol Chem. 2010 Aug 13;285(33):25812-21. doi: 10.1074/jbc.M109.098442. Epub 2010 Jun 16.
6
Nucleoplasmic mobilization of nucleostemin stabilizes MDM2 and promotes G2-M progression and cell survival.
J Cell Sci. 2008 Dec 15;121(Pt 24):4037-46. doi: 10.1242/jcs.037952. Epub 2008 Nov 25.
7
Nucleostemin: a multiplex regulator of cell-cycle progression.
Trends Cell Biol. 2008 Dec;18(12):575-9. doi: 10.1016/j.tcb.2008.09.003. Epub 2008 Oct 23.
8
GNL3L depletion destabilizes MDM2 and induces p53-dependent G2/M arrest.
Oncogene. 2011 Apr 7;30(14):1716-26. doi: 10.1038/onc.2010.550. Epub 2010 Dec 6.
9
Nucleostemin stabilizes ARF by inhibiting the ubiquitin ligase ULF.
Oncogene. 2015 Mar 26;34(13):1688-97. doi: 10.1038/onc.2014.103. Epub 2014 Apr 28.
10
Mutual protection of ribosomal proteins L5 and L11 from degradation is essential for p53 activation upon ribosomal biogenesis stress.
Proc Natl Acad Sci U S A. 2012 Dec 11;109(50):20467-72. doi: 10.1073/pnas.1218535109. Epub 2012 Nov 20.

引用本文的文献

1
NOC1 is a direct MYC target, and its protein interactome dissects its activity in controlling nucleolar function.
Front Cell Dev Biol. 2023 Dec 28;11:1293420. doi: 10.3389/fcell.2023.1293420. eCollection 2023.
4
RBM10, a New Regulator of p53.
Cells. 2020 Sep 16;9(9):2107. doi: 10.3390/cells9092107.
6
Differential expression of nucleostemin in the cytoplasm and nuclei of normal and cancerous cell lines.
Turk J Biol. 2018 Jun 13;42(3):250-258. doi: 10.3906/biy-1712-10. eCollection 2018.
7
Nucleostemin reveals a dichotomous nature of genome maintenance in mammary tumor progression.
Oncogene. 2019 May;38(20):3919-3931. doi: 10.1038/s41388-019-0710-0. Epub 2019 Jan 28.
8
Chromatin Stability as a Target for Cancer Treatment.
Bioessays. 2019 Jan;41(1):e1800141. doi: 10.1002/bies.201800141.
10
Nucleostemin Knockdown Sensitizes Hepatocellular Carcinoma Cells to Ultraviolet and Serum Starvation-Induced Apoptosis.
PLoS One. 2015 Oct 30;10(10):e0141678. doi: 10.1371/journal.pone.0141678. eCollection 2015.

本文引用的文献

1
A genome-scale protein interaction profile of Drosophila p53 uncovers additional nodes of the human p53 network.
Proc Natl Acad Sci U S A. 2010 Apr 6;107(14):6322-7. doi: 10.1073/pnas.1002447107. Epub 2010 Mar 22.
2
Signaling to p53: ribosomal proteins find their way.
Cancer Cell. 2009 Nov 6;16(5):369-77. doi: 10.1016/j.ccr.2009.09.024.
3
Identification of tumor-initiating cells in a highly aggressive brain tumor using promoter activity of nucleostemin.
Proc Natl Acad Sci U S A. 2009 Oct 6;106(40):17163-8. doi: 10.1073/pnas.0905016106. Epub 2009 Sep 17.
5
Ribosomal protein S7 is both a regulator and a substrate of MDM2.
Mol Cell. 2009 Aug 14;35(3):316-26. doi: 10.1016/j.molcel.2009.07.014.
6
Modes of p53 regulation.
Cell. 2009 May 15;137(4):609-22. doi: 10.1016/j.cell.2009.04.050.
7
Depletion of guanine nucleotides leads to the Mdm2-dependent proteasomal degradation of nucleostemin.
Cancer Res. 2009 Apr 1;69(7):3004-12. doi: 10.1158/0008-5472.CAN-08-3413. Epub 2009 Mar 24.
8
Critical role of nucleostemin in pre-rRNA processing.
J Biol Chem. 2009 Feb 20;284(8):4968-77. doi: 10.1074/jbc.M804594200. Epub 2008 Dec 23.
9
Mdm2 regulates p53 mRNA translation through inhibitory interactions with ribosomal protein L26.
Mol Cell. 2008 Oct 24;32(2):180-9. doi: 10.1016/j.molcel.2008.08.031.
10
Aberrant expression of nucleostemin activates p53 and induces cell cycle arrest via inhibition of MDM2.
Mol Cell Biol. 2008 Jul;28(13):4365-76. doi: 10.1128/MCB.01662-07. Epub 2008 Apr 21.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验